SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001193125-18-191628
Filing Date
2018-06-13
Accepted
2018-06-13 16:09:42
Documents
60

Document Format Files

Seq Description Document Type Size
1 S-1 d573021ds1.htm S-1 889983
2 EX-4.12 d573021dex412.htm EX-4.12 75956
3 EX-5.1 d573021dex51.htm EX-5.1 9780
4 EX-23.1 d573021dex231.htm EX-23.1 1714
11 GRAPHIC g573021dsp68.jpg GRAPHIC 4814
  Complete submission text file 0001193125-18-191628.txt   3429047

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT oxgn-20180331.xml EX-101.INS 569574
6 XBRL TAXONOMY EXTENSION SCHEMA oxgn-20180331.xsd EX-101.SCH 35915
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE oxgn-20180331_cal.xml EX-101.CAL 44381
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE oxgn-20180331_def.xml EX-101.DEF 93157
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE oxgn-20180331_lab.xml EX-101.LAB 297926
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE oxgn-20180331_pre.xml EX-101.PRE 199490
Mailing Address 701 GATEWAY BLVD. SUITE 210 SOUTH SAN FRANCISCO CA 94080
Business Address 701 GATEWAY BLVD. SUITE 210 SOUTH SAN FRANCISCO CA 94080 650-635-7000
MATEON THERAPEUTICS INC (Filer) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-225600 | Film No.: 18896817
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1